TGFB1 and hemorrhagic cystitis: The higher female prevalence of IC, as well as the limited clinical success in the treatment of hemorrhagic cystitis with estrogens [57,58], support the notion that TGF-β1 is a central molecular mediator governing the gender-related differences in the response to CYP reported here.